Literature DB >> 6554212

[Early bladder function disorders following Wertheim surgery. Causes and therapeutic consequences].

F Christ, U Wagner, G Debus.   

Abstract

The bladder function of forty five women was studied once before and three times following a Wertheim Operation for Carcinoma of the Cervix. Three quarters of the patients had a diminished bladder capacity two weeks after surgery with an increased bladder filling pressure and a decreased urethral occlusion pressure. After eight and twenty weeks the pre-operative state was almost reached. However there was no complete restoration of the function at that time. Almost all women had a disturbance of the bladder sensitivity. Modern investigations of bladder physiology show that the lax bladder is an expected post-operative neurogenic problem of the vesical plexus. At first this is masked by a hypertonic bladder due to muscle trauma. The postoperative decrease of the urethral occlusion pressure appears to be caused by a partial injury of sympathic nerve fibers. The problem of functional infravesical obstruction is discussed. The treatment is at first accomplished by general perioperative measures. Later on receptor effective drugs are used as necessary following a repeat urodynamic investigation.

Entities:  

Mesh:

Year:  1983        PMID: 6554212     DOI: 10.1055/s-2008-1036634

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  3 in total

1.  Prophylaxis and treatment of bladder dysfunction after Wertheim-Meigs operation: the positive effect of early postoperative detrusor stimulation using the cholinergic drug betanecholchloride.

Authors:  B Kemp; H J Kitschke; M Goetz; W Heyl
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

2.  Changes in urethral closure pressure after radical hysterectomy for cervical cancer.

Authors:  F Christ; G Debus-Thiede; U Wagner
Journal:  Arch Gynecol       Date:  1985

3.  Urodynamics following radical abdominal hysterectomy for cervical cancer.

Authors:  G Ralph; K Tamussino; W Lichtenegger
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.